World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
61
Citations
19453
World Ranking
11143
National Ranking
4825

Overview

Joe B. Harford is affiliated with the National Institutes of Health in the United States. Their research primarily focuses on medicine, with significant contributions in biochemistry, genetics and molecular biology, as well as immunology and microbiology. The scientist's work spans several subfields including immunology, oncology, genetics, pathology and forensic medicine, and biotechnology.

Their research encompasses a range of topics such as virus-based gene therapy research, cancer immunotherapy and biomarkers, cancer mechanisms and therapy, cancer research and treatments, pesticide exposure and toxicity, cholinesterase and neurodegenerative diseases, and SARS-CoV-2 and COVID-19.

Joe B. Harford has authored several recent papers, including:

  • "TP53 Gene Therapy as a Potential Treatment for Patients with COVID-19" (2022, Viruses)
  • "A Second Career for p53 as A Broad-Spectrum Antiviral?" (2023, Viruses)

Additional publications relevant to the broader research area include studies on cancer and nanomedicine, although not authored by Harford, such as the works published in Cells and the Journal of Clinical Oncology. The frequent publication venues for Harford's work reflect a focus on immunology and nanomedicine with multiple papers appearing in Viruses and the International Journal of Nanomedicine.

Frequent coauthors collaborating with Harford include Esther H. Chang, Sang Soo Kim, Kathleen F. Pirollo, Manish Moghe, and Antonina Rait, indicating interdisciplinary or collaborative efforts within related biomedical research fields.

The topics and fields of study associated with Joe B. Harford indicate ongoing involvement in research related to cancer treatment strategies, particularly the use of gene therapy, immunomodulation, and addressing viral infections including SARS-CoV-2. The work on p53 gene therapy and its potential applications in both oncology and antiviral therapies is a critical aspect of Harford's research portfolio.

Best Publications

  • Regulating the fate of mRNA: The control of cellular iron metabolism

    Richard D. Klausner;Tracey A. Rouault;Joe B. Harford

  • Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation

    JL Casey;MW Hentze;DM Koeller;SW Caughman

  • Binding of apotransferrin to K562 cells: explanation of the transferrin cycle

    R D Klausner;G Ashwell;J van Renswoude;J B Harford

  • Identification of the iron-responsive element for the translational regulation of human ferritin mRNA

    MW Hentze;SW Caughman;TA Rouault;JG Barriocanal

  • Receptor-mediated endocytosis of transferrin and the uptake of fe in K562 cells: identification of a nonlysosomal acidic compartment

    J van Renswoude;K R Bridges;J B Harford;R D Klausner

  • Antigen activation of murine T cells induces tyrosine phosphorylation of a polypeptide associated with the T cell antigen receptor

    Lawrence E. Samelson;Maitray D. Patel;Allan M. Weissman;Joe B. Harford

  • Oxidation-reduction and the molecular mechanism of a regulatory RNA-protein interaction.

    Matthias W. Hentze;Tracey A. Rouault;Joe B. Harford;Richard D. Klausner

  • Iron regulation of transferrin receptor mRNA levels requires iron-responsive elements and a rapid turnover determinant in the 3' untranslated region of the mRNA.

    J.L. Casey;D.M. Koeller;V.C. Ramin;R.D. Klausner

  • Binding of a cytosolic protein to the iron-responsive element of human ferritin messenger RNA.

    TA Rouault;MW Hentze;SW Caughman;JB Harford

  • Identification of the components of the murine T cell antigen receptor complex

    Lawrence E. Samelson;Joe B. Harford;Richard D. Klausner

  • Evidence that the pathway of transferrin receptor mRNA degradation involves an endonucleolytic cleavage within the 3' UTR and does not involve poly(A) tail shortening.

    Roberta Binder;Jill A. Horowitz;James P. Basilion;David M. Koeller

  • cis-trans models for post-transcriptional gene regulation.

    Richard D. Klausner;Joe B. Harford

  • Cellular regulation of the iron-responsive element binding protein: disassembly of the cubane iron-sulfur cluster results in high-affinity RNA binding.

    David J. Haile;Tracey A. Rouault;Joe B. Harford;Mary Claire Kennedy

  • Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010

    Benjamin O Anderson;Eduardo Cazap;Nagi S El Saghir;Cheng-Har Yip

  • Structural relationship between an iron-regulated RNA-binding protein (IRE-BP) and aconitase: functional implications.

    Tracey A. Rouault;C.David Stout;Stamatina Kaptain;Joe B. Harford

  • Reciprocal control of RNA-binding and aconitase activity in the regulation of the iron-responsive element binding protein: role of the iron-sulfur cluster.

    David J. Haile;Tracey A. Rouault;Careen K. Tang;Jean Chin

  • A cis-acting element is necessary and sufficient for translational regulation of human ferritin expression in response to iron.

    M W Hentze;T A Rouault;S W Caughman;A Dancis

  • Challenges and opportunities in cancer control in Africa: a perspective from the African Organisation for Research and Training in Cancer

    Imran O Morhason-Bello;Folakemi Odedina;Timothy R Rebbeck;Joe Harford

  • A cytosolic protein binds to structural elements within the iron regulatory region of the transferrin receptor mRNA

    David M. Koeller;John L. Casey;Matthias W. Hentze;Elizabeth M. Gerhardt

  • A regulated RNA binding protein also possesses aconitase activity.

    Stamatina Kaptain;William E. Downey;Careen Tang;Caroline Philpott

Frequent Co-Authors

Tracey A. Rouault
Tracey A. Rouault National Institutes of Health
Matthias W. Hentze
Matthias W. Hentze European Molecular Biology Laboratory
Gilbert Ashwell
Gilbert Ashwell National Institutes of Health
Sofia D. Merajver
Sofia D. Merajver University of Michigan–Ann Arbor
Esther H. Chang
Esther H. Chang Georgetown University Medical Center
Julie R. Gralow
Julie R. Gralow American Society of Clinical Oncology
Allan M. Weissman
Allan M. Weissman National Institutes of Health
Andrew Dancis
Andrew Dancis University of Pennsylvania
Lawrence E. Samelson
Lawrence E. Samelson National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Joe B. Harford

Trending Scientists

Recently Published Articles